Cipla Peer Comparison

NSE: CIPLA | BSE: 500087

₹1,314.00

₹-10.10 (-0.76%)

As on 21-Oct-2026IST

Market cap

₹1,06,138 Cr

Revenue (TTM)

₹28,324 Cr

P/E Ratio

31.5

P/B Ratio

Div. Yield

1 %

Edit

	Cipla	Sun Pharmaceutical	Torrent Pharma	Zydus Lifesciences	Dr. Reddy'S Labs
Market cap (₹ Cr)	1,06,138	4,18,684	1,72,213	1,11,451	1,03,304
Revenue (₹ Cr)	28,324	59,911	15,723	28,592	33,228
Net Profit (₹ Cr)	3,364.84	12,172.70	2,156.00	4,492.20	3,169.30
Net Margin (%)	11.54	19.41	13.77	14.92	9.15
RoE (%)	10.63	15.65	26.88	18.78	8.72
Price to Earnings	31.49	34.61	78.96	24.70	32.06
Price-To-Book	3.02	4.84	19.19	4.13	2.71

Income Statement (₹ Cr)

	Cipla	Sun Pharmaceutical	Torrent Pharma	Zydus Lifesciences	Dr. Reddy'S Labs
Operating Revenue	28,324.40	59,910.52	15,723.00	28,591.70	33,227.90
Total Income	29,158.75	62,725.79	15,654.00	30,111.40	34,650.70
Total Expenditure	22,985.32	42,647.50	10,532.00	21,334.70	28,088.10
EBITDA	5,339.08	17,263.02	5,191.00	7,257.00	5,139.80
Depreciation	1,304.52	2,976.02	1,511.00	1,724.60	2,119.30
EBIT	4,034.56	14,287.00	3,680.00	5,532.40	3,020.50
Interest	57.37	363.78	634.00	510.20	416.30
Other Income	834.35	2,815.27	-69.00	1,519.70	1,422.80
Exceptional Items	-275.91	-693.57	-110.00	-534.80	0.00
Profit before Tax	4,535.63	16,044.92	2,867.00	6,007.10	4,027.00
Provision for Tax	1,170.79	3,872.22	711.00	1,514.90	857.70
Profit after Tax	3,364.84	12,172.70	2,156.00	4,492.20	3,169.30

	Cipla	Sun Pharmaceutical	Torrent Pharma	Zydus Lifesciences	Dr. Reddy'S Labs
Shareholder's Funds	34,431.95	83,570.09	8,389.00	27,111.40	37,891.50
Minority Interest	14.98	-21.43	25.00	-79.70	38.90
Non-Current Liabilities	962.15	2,283.44	18,384.00	7,112.50	3,145.10
Current Liabilities	7,013.59	22,622.04	8,343.00	15,711.90	16,747.40
Total Liabilities	42,342.71	1,08,407.20	43,613.69	50,672.60	56,576.70

	Cipla	Sun Pharmaceutical	Torrent Pharma	Zydus Lifesciences	Dr. Reddy'S Labs
Non-Current Assets	15,471.21	43,711.29	33,955.00	31,677.20	27,204.00
Current Assets	24,145.86	63,860.29	9,392.00	19,906.10	30,179.30
Total Assets	42,342.71	1,08,407.20	43,613.69	50,672.60	56,576.70
Total Debt*	257.97	4,081.61	14,798.24	11,769.50	7,734.10
Net Current Assets	17,132.27	41,238.25	1,049.00	4,194.20	13,431.90
Contingent Liabilities	987.37	1,587.05	379.25	989.90	336.14

	Cipla	Sun Pharmaceutical	Torrent Pharma	Zydus Lifesciences	Dr. Reddy'S Labs
Cash From Operating Activities	3,940.02	12,419.18	3,022.71	2,116.60	5,673.70
Cash Flow from Investing Activities	-2,326.13	-11,344.05	-12,712.41	-8,296.10	-6,549.30
Cash from Financing Activities	-1,233.65	-2,512.55	10,150.60	5,806.90	829.00
Net Cash Inflow / Outflow	380.24	-1,437.42	460.90	-372.60	-46.60

	Cipla	Sun Pharmaceutical	Torrent Pharma	Zydus Lifesciences	Dr. Reddy'S Labs
ROCE (%)	16.00	19.11	19.27	21.39	13.75
ROE (%)	10.63	15.65	26.88	18.78	8.72
ROA (%)	8.42	12.12	7.27	10.03	5.89
EBIT Margin (%)	14.24	23.85	23.41	19.35	9.09
Net Margin (%)	11.54	19.41	13.77	14.92	9.15
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Cipla	Sun Pharmaceutical	Torrent Pharma	Zydus Lifesciences	Dr. Reddy'S Labs
Revenue Growth (%)	1.85	11.41	32.85	21.11	-0.87
EBIT Growth (%)	-33.61	8.10	20.66	-8.99	-55.06
Net Profit Growth (%)	-37.77	16.92	7.69	-3.14	-44.66
EPS Growth (%)	-33.63	10.18	12.04	4.31	-43.29
Book Value Growth (%)	10.59	15.72	10.51	13.19	12.99

	Cipla	Sun Pharmaceutical	Torrent Pharma	Zydus Lifesciences	Dr. Reddy'S Labs
Price / Earnings	29.56	32.81	67.38	22.68	32.14
Price / Book Value	3.01	4.79	19.10	4.11	2.71
Dividend Yield (%)	0.99	0.93	0.84	0.09	0.65
EV/EBITDA	18.19	22.36	35.48	15.91	20.29
Market Cap (₹ Cr)	98,797.18	4,21,639.92	1,42,851.87	87,643.18	1,04,763.81

	Cipla	Sun Pharmaceutical	Torrent Pharma	Zydus Lifesciences	Dr. Reddy'S Labs
Debt to Equity	0.00	0.00	1.39	0.12	0.00
Short term debt to equity ratio	0.00	0.05	0.35	0.16	0.16
Current Ratio	3.44	2.82	1.13	1.27	1.80
Quick Ratio	2.50	2.31	0.75	0.91	1.35
Interest Coverage	80.06	45.11	5.52	12.77	10.67

	Cipla	Sun Pharmaceutical	Torrent Pharma	Zydus Lifesciences	Dr. Reddy'S Labs
Debtors to sales (%)	19.84	25.89	19.28	18.94	30.47
Asset Turnover	0.71	0.60	0.53	0.64	0.62
Receivable days	52.05	89.14	45.41	33.55	103.79
Inventory Days	57.25	67.85	52.67	33.80	79.94
Payable days	115.96	213.72	244.06	149.82	84.78
Cash Conversion Cycle	-6.65	-56.72	-145.98	-82.46	98.95

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.